Dr. Edward Louis Middleman MD Medical Oncologist

Dr. Edward Middleman is a medical oncologist in Duncanville, Texas and is affiliated with multiple hospitals in the area, including Methodist Charlton Medical Center and Methodist Dallas Medical Center. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice for 49 years. He is one of 12 doctors at Methodist Charlton Medical Center and one of 11 at Methodist Dallas Medical Center who specialize in Medical Oncology.

Are you Dr. Middleman? Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Education & Medical Training

University of Pittsburgh Medical Center
Residency, Internal Medicine, 1968–1969

Montefiore University Hospital - Upmc
Residency, Internal Medicine, 1965–1966

University of Texas M D Anderson Cancer Center
Residency, Internal Medicine, 1969–1971

University of Pittsburgh School of Medicine
Class of 1965

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

TN State Medical License
Active through 2015

TX State Medical License
Active through 2014

ID State Medical License
Active through 2013

Publications & Presentations

A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
Lynch, T.J., Fenton, D., Hirsh, V., Bodkin, D., Middleman, E.L., Chiappori, A., Halmos, B., Favis, R., Liu, H., Trepicchio, W.L., Eton, O., Shepherd, F.A.

Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
Butts, C.A., Bodkin, D., Middleman, E.L., Englund, C.W., Ellison, D., Alam, Y., Kreisman, H., Graze, P., Maher, J., Ross, H.J., Ellis, P.M., McNulty, W., Kaplan, E., Pautret, V., Weber, M.R., Shepherd, F.A.

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
Talbot, S.M., Rankin, C., Taub, R.N., Balcerzak, S.P., Bhoopalam, N., Chapman, R.A., Baker, L.H., Middleman, E.L., Antman, K.H.

See all 16 publications

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Duncanville, TX See all Medical Oncologists in Texas

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.